HitGen Partner BioAge Labs Doses First Participant in Phase 2 Trial of BGE-102, a Novel Oral NLRP3 Inhibitor for Cardiovascular Risk Reduction BGE-102, a potent, structurally novel, orally available, brain-penetrant small molecule NLRP3 inhibitor… CISION PRNewswireJuly 14, 2026
Press Release NYSE Content Update: Madrona Highlights Private Companies Building AI Apps NYSE issues a pre-market daily advisory direct from the trading floor. NEW… CISION PRNewswireJuly 14, 2026
Wafra Holds Final Close of Constellation Generation V at $2 Billion Latest vehicle exceeds its $1.5 billion target, expands Capital Constellation’s global institutional… CISION PRNewswireJuly 14, 2026
Trio Mobil Receives Frost & Sullivan's 2026 Global Technology Innovation Leadership Recognition for Excellence in AI-Based Industrial Safety and SIF Prevention Recognition underscores Trio Mobil’s leadership in AI-driven industrial safety intelligence, advancing proactive… CISION PRNewswireJuly 14, 2026
Optro Launches 'Optro Partner Connect' to Power Global GRC Ecosystem Growth The new partner program offers partners flexible ways to go to market,… CISION PRNewswireJuly 14, 2026
Press Release PartnerOne Acquires ISI Analytics to Accelerate Enterprise Communications Intelligence and Customer Experience Acquisition positions ISI Analytics for continued growth and advances innovation in enterprise… CISION PRNewswireJuly 14, 2026
Press Release Tech Rayence Launches 'SHINE,' a Next-Generation X-ray Image Processing Technology for Low Dose Imaging – Development of next-generation denoising image processing technology ‘SHINE’ completed; full-scale commercialization… CISION PRNewswireJuly 14, 2026
Press Release TINECO ACHIEVES NO. 1 POSITION ACROSS FIVE OF AMAZON'S LARGEST GLOBAL MARKETPLACES Company ranks No. 1 in Amazon’s wet & dry vacuum cleaner (floor… CISION PRNewswireJuly 14, 2026
